Intracellular level of HIF-1α in PKH-fluorescent positive cells treated with COPD-EVs was 2.2-fold increased compared to the HS-EV treatment (p < 0.01) (Fig. 4C). The gene discussed is HIF1A; the disease is chronic obstructive pulmonary disease.